Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03900624 · ClinicalTrials.gov registry record · Phase 4
Ideal Steroids for Asthma Treatment in the PICU
A Phase 4 study, sponsored by Johns Hopkins All Children's Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 92
- Enrollment target
NCT03900624 is a Phase 4 study that has completed, run by Johns Hopkins All Children's Hospital. The registered enrollment target is 92 participants.
The verdict
NCT03900624, a Phase 4 study, has completed, sponsored by Johns Hopkins All Children's Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 92 participants
- Enrollment target
Study Summary
Determine if differences in (1) pediatric intensive care unit length of stay, (2) continuous nebulized albuterol duration, and (3) a composite outcome of advanced asthma therapy incidence including use of non-invasive ventilation (NIV), terbutaline, inhaled helium and mechanical ventilation between cohorts of children admitted with status asthmaticus to the PICU treated with either IV dexamethasone (DM) or methylprednisolone (MP).
Interventions
- DRUG Dexamethasone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2019-04-21 |
| Est. Completion | 2022-05-15 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03900624
The ClinicalTrials.gov registry entry for NCT03900624 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins All Children's Hospital, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dexamethasone is the first listed.
NCT03900624 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03900624 about?
NCT03900624 is a clinical study titled "Ideal Steroids for Asthma Treatment in the PICU". Determine if differences in (1) pediatric intensive care unit length of stay, (2) continuous nebulized albuterol duration, and (3) a composite outcome of advanced asthma therapy incidence including use of non-invasive ventilation (NIV), terbutaline, inhaled helium and mechanical ventilation between ...
What is the current status of trial NCT03900624?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 92 participants. The study started on 2019-04-21. Estimated completion is 2022-05-15.
What interventions are being tested in trial NCT03900624?
The interventions under investigation include: Dexamethasone (DRUG).
Who is sponsoring clinical trial NCT03900624?
This trial is sponsored by Johns Hopkins All Children's Hospital, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.